Arjo AB (publ) (ARRJF)
ARRJF Stock Price Chart
Explore Arjo AB (publ) interactive price chart. Choose custom timeframes to analyze ARRJF price movements and trends.
ARRJF Company Profile
Discover essential business fundamentals and corporate details for Arjo AB (publ) (ARRJF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
21 Aug 2018
Employees
6.50K
Website
https://www.arjo.comCEO
Niclas Sjosward
Description
Arjo AB (publ) develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, treatment and prevention of pressure injuries and leg ulcers, prevention of deep vein thrombosis, treatment of edema, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, as well as clinical consulting, maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. The company was founded in 1957 and is headquartered in Malmö, Sweden.
ARRJF Financial Timeline
Browse a chronological timeline of Arjo AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 27 Apr 2026
Upcoming earnings on 28 Jan 2026
Upcoming earnings on 22 Oct 2025
Earnings released on 11 Jul 2025
EPS came in at $0.04 falling short of the estimated $0.04 by -9.93%, while revenue for the quarter reached $279.82M , missing expectations by -89.75%.
Earnings released on 29 Apr 2025
EPS came in at $0.03 falling short of the estimated $0.05 by -37.51%, while revenue for the quarter reached $285.99M , missing expectations by -89.86%.
Earnings released on 30 Jan 2025
EPS came in at $0.06 falling short of the estimated $0.07 by -11.69%, while revenue for the quarter reached $269.01M , missing expectations by -90.66%.
Dividend declared on 30 Jan 2025
A dividend of $0.10 per share was announced, adjusted to $0.10. The dividend was paid on 7 May 2025.
Earnings released on 17 Oct 2024
EPS came in at $0.03 falling short of the estimated $0.04 by -33.79%, while revenue for the quarter reached $263.51M , missing expectations by -4.18%.
Earnings released on 12 Jul 2024
EPS came in at $0.04 falling short of the estimated $0.05 by -11.69%, while revenue for the quarter reached $265.86M , beating expectations by +0.69%.
Earnings released on 18 Apr 2024
EPS came in at $0.04 falling short of the estimated $0.05 by -6.02%, while revenue for the quarter reached $254.38M , beating expectations by +15.61%.
Earnings released on 30 Jan 2024
EPS came in at $0.07 surpassing the estimated $0.06 by +22.55%, while revenue for the quarter reached $284.77M , beating expectations by +0.26%.
Dividend declared on 30 Jan 2024
A dividend of $0.08 per share was announced, adjusted to $0.09. The dividend was paid on 25 Apr 2024.
Earnings released on 30 Sept 2023
EPS came in at $0.03 falling short of the estimated $0.04 by -8.21%, while revenue for the quarter reached $252.18M , beating expectations by +0.77%.
Earnings released on 30 Jun 2023
EPS came in at $0.03 surpassing the estimated $0.03 by +2.80%, while revenue for the quarter reached $247.55M , beating expectations by +1.14%.
Earnings released on 31 Mar 2023
EPS came in at $0.04 surpassing the estimated $0.03 by +24.25%, while revenue for the quarter reached $253.46M , beating expectations by +4.05%.
Dividend declared on 26 Jan 2023
A dividend of $0.08 per share was announced, adjusted to $0.09. The dividend was paid on 27 Apr 2023.
Earnings released on 25 Jan 2023
EPS came in at $0.54 falling short of the estimated $0.59 by -8.47%, while revenue for the quarter reached $262.37M , beating expectations by +1.47%.
Earnings released on 28 Oct 2022
EPS came in at $0.34 falling short of the estimated $0.56 by -39.29%, while revenue for the quarter reached $224.82M , beating expectations by +0.12%.
Earnings released on 14 Jul 2022
EPS came in at $0.41 falling short of the estimated $0.74 by -44.59%, while revenue for the quarter reached $233.78M , missing expectations by -1.11%.
Earnings released on 22 Apr 2022
EPS came in at $0.62 surpassing the estimated $0.52 by +19.23%, while revenue for the quarter reached $252.60M , beating expectations by +3.30%.
Dividend declared on 7 Feb 2022
A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 29 Apr 2022.
Earnings released on 3 Feb 2022
EPS came in at $0.77 matching the estimated $0.77, while revenue for the quarter reached $999.77M , beating expectations by +264.77%.
Earnings released on 28 Oct 2021
EPS came in at $0.71 surpassing the estimated $0.63 by +12.70%, while revenue for the quarter reached $255.90M .
Earnings released on 15 Jul 2021
EPS came in at $0.71 surpassing the estimated $0.61 by +16.39%, while revenue for the quarter reached $256.42M .
Earnings released on 27 Apr 2021
EPS came in at $0.66 surpassing the estimated $0.53 by +24.53%, while revenue for the quarter reached $247.93M .
Earnings released on 3 Feb 2021
EPS came in at $0.73 falling short of the estimated $0.92 by -20.65%, while revenue for the quarter reached $1.10B .
Dividend declared on 3 Feb 2021
A dividend of $0.10 per share was announced, adjusted to $0.09. The dividend was paid on 4 May 2021.
Earnings released on 28 Oct 2020
EPS came in at $0.49 surpassing the estimated $0.32 by +53.12%, while revenue for the quarter reached $239.57M , beating expectations by +51.37K%.
ARRJF Stock Performance
Access detailed ARRJF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.